Chinese company CanSino Biologics Inc has plans to ramp up production of their COVID-19 vaccine following the completion of Phase III clinical trials. The company plans to produce 300 million doses a year. Yourway has a 11,700 square foot local depot located in Beijing, China and has capacity globally to help facilitate clinical trials anywhere.